You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

KEMEYA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Kemeya patents expire, and when can generic versions of Kemeya launch?

Kemeya is a drug marketed by Sun Pharm and is included in one NDA.

The generic ingredient in KEMEYA is drospirenone; ethinyl estradiol. There are eleven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for KEMEYA?
  • What are the global sales for KEMEYA?
  • What is Average Wholesale Price for KEMEYA?
Summary for KEMEYA
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:KEMEYA at DailyMed
Drug patent expirations by year for KEMEYA

US Patents and Regulatory Information for KEMEYA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm KEMEYA drospirenone; ethinyl estradiol TABLET;ORAL-28 202138-001 Mar 13, 2019 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.